The ROE as of November 2024 (TTM) for Cardio Diagnostics Holdings, Inc. (CDIO) is -258.81%

According to Cardio Diagnostics Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -258.81%. This represents a change of 291.73% compared to the average of -66.07% of the last 4 quarters.

Cardio Diagnostics Holdings, Inc. (CDIO) Historical ROE (quarterly & annually)

How has CDIO ROE performed in the past?

The mean historical ROE of Cardio Diagnostics Holdings, Inc. over the last ten years is -363.03%. The current -258.81% ROE has changed -28.71% with respect to the historical average. Over the past ten years (40 quarters), CDIO's ROE was at its highest in in the December 2021 quarter at -0.22%. The ROE was at its lowest in in the June 2021 quarter at -387.98%.

Cardio Diagnostics Holdings, Inc. (CDIO) ROE by Quarter and Year

Discovering the peaks and valleys of Cardio Diagnostics Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cardio Diagnostics Holdings, Inc. (CDIO) Average ROE

How has CDIO ROE performed in the past?

The current ROE of Cardio Diagnostics Holdings, Inc. (CDIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cardio Diagnostics Holdings, Inc. (CDIO) ROE vs. Peers

How is CDIO’s ROE compared to its peers?

Cardio Diagnostics Holdings, Inc.’s ROE is greater than Immix Biopharma, Inc. (-102.10%), less than CNS Pharmaceuticals, Inc. (695.91%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Zura Bio Limited (-39.61%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than 180 Life Sciences Corp. (-559.06%), less than Pyxis Oncology, Inc. (0%), greater than Altamira Therapeutics Ltd. (-36.23%), less than Elevation Oncology, Inc. (783.37%), greater than ZyVersa Therapeutics, Inc. (-59.73%), greater than VectivBio Holding AG (-25512.50%), greater than AVROBIO, Inc. (-56.92%), less than null (29.68%),

Build a custom stock screener for Cardio Diagnostics Holdings, Inc. (CDIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardio Diagnostics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cardio Diagnostics Holdings, Inc. (CDIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cardio Diagnostics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.